Literature DB >> 22099757

Role of islet culture on angiogenic and inflammatory mechanisms.

K Vivot1, N Jeandidier, C Dollinger, W Bietiger, M Pinget, S Sigrist, A Langlois.   

Abstract

Early events hampering islet engraftment may relate to instant blood-mediated inflammatory reaction (IBMIR) and to insufficient islet revascularization inducing β-cell death. We evaluated the influence of time of culture on angiogenic and inflammatory cellular mechanisms in islet loss in vitro. Rat pancreatic islets cultured for 0, 12, 24, and 48 hours were assessed for functionality using glucose stimulation tests and identification of signaling pathways using polymerase chain reaction (PCR) arrays. Islet functionality decreased significantly immediately. Index of stimulation (IS) was decreased to 2.29 ± 1.05 after 48 hours of culture versus 18.47 ± 4.84 at 0 hours (P < .001). Gene expression studies at 12 hours of culture showed significant overexpression of proinflammatory cytokines and chemokines--interleukin (IL)-6 884.22 ± 282.58 (P < .001) and Cxcl-1 448.09 ± 196.05-fold change (P < .01). Moreover, islets exhibited significant under-expression after 48 hours of genes encoding angiogenic growth factors, such as epidermal growth factor, vascular endothelial growth factor, platelet endothelial cell adhesion molecule 1, a major protein involved in angiogenesis: 0.07 ± 0.02, 0.11 ± 0.08 (P < .001), and 0.17 ± 0.15-fold change (P < .01) respectively. Moreover, tissue inhibitor of metalloproteinases 1, an inhibitor of metallopeptidase, was significantly more over-expressed, namely 54.58 ± 18.08 at 12 hours of culture versus 0.93 ± 0.15/fold change at 0 hours. This study revealed current culture conditions to be deleterious for islet engraftment, possibly due to expression of angiogenic genes and proinflamatory genes during culture.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22099757     DOI: 10.1016/j.transproceed.2011.09.096

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

1.  Pro-inflammatory and pro-oxidant status of pancreatic islet in vitro is controlled by TLR-4 and HO-1 pathways.

Authors:  Kevin Vivot; Allan Langlois; William Bietiger; Stéphanie Dal; Elodie Seyfritz; Michel Pinget; Nathalie Jeandidier; Elisa Maillard; Jean-Pierre Gies; Séverine Sigrist
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

2.  Development and Application of a Semi quantitative Scoring Method for Ultrastructural Assessment of Acute Stress in Pancreatic Islets.

Authors:  Nicola J Dyson; Nicole Kattner; Minna Honkanen-Scott; Bethany Hunter; Jennifer A Doyle; Kathryn White; Tracey S Davey; Rutger J Ploeg; Yvonne A Bury; Dina G Tiniakos; James A M Shaw; William E Scott
Journal:  Transplant Direct       Date:  2021-12-16

Review 3.  Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges.

Authors:  Anthony Bruni; Boris Gala-Lopez; Andrew R Pepper; Nasser S Abualhassan; Am James Shapiro
Journal:  Diabetes Metab Syndr Obes       Date:  2014-06-23       Impact factor: 3.168

4.  Improvement of islet graft function using liraglutide is correlated with its anti-inflammatory properties.

Authors:  A Langlois; S Dal; K Vivot; C Mura; E Seyfritz; W Bietiger; C Dollinger; C Peronet; E Maillard; M Pinget; N Jeandidier; S Sigrist
Journal:  Br J Pharmacol       Date:  2016-11-06       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.